- Title
- Randomized phase II trial of cisplatin with mitomycin or doxorubicin for malignant mesothelioma by the cancer and leukemia group B
- Creators
- A. P CHAHINIAN - Mount Sinai school medicine, dep. neoplastic diseases, New York NY 10029, United StatesK ANTMAN - Mount Sinai school medicine, dep. neoplastic diseases, New York NY 10029, United StatesN. J VOGELZANG - Mount Sinai school medicine, dep. neoplastic diseases, New York NY 10029, United StatesM. R GREEN - Mount Sinai school medicine, dep. neoplastic diseases, New York NY 10029, United StatesM GOUTSOU - Mount Sinai school medicine, dep. neoplastic diseases, New York NY 10029, United StatesJ. M CORSON - Mount Sinai school medicine, dep. neoplastic diseases, New York NY 10029, United StatesY SUZUKI - Mount Sinai school medicine, dep. neoplastic diseases, New York NY 10029, United StatesC MODEAS - Mount Sinai school medicine, dep. neoplastic diseases, New York NY 10029, United StatesJ. E HERNDON - Mount Sinai school medicine, dep. neoplastic diseases, New York NY 10029, United StatesJ AISNER - Mount Sinai school medicine, dep. neoplastic diseases, New York NY 10029, United StatesR. R ELLISON - Mount Sinai school medicine, dep. neoplastic diseases, New York NY 10029, United StatesL LEONE - Mount Sinai school medicine, dep. neoplastic diseases, New York NY 10029, United States
- Publication Details
- Journal of clinical oncology, Vol.11(8), pp.1559-1565
- Date published
- 1993
- Publisher
- Lippincott Williams & Wilkins
- Academic Unit
- Lung Cancer/Thoracic Oncology Program
- Language
- English
- Resource Type
- Journal article
- Identifiers
- 991031654942804646
Journal article
Randomized phase II trial of cisplatin with mitomycin or doxorubicin for malignant mesothelioma by the cancer and leukemia group B
Journal of clinical oncology, Vol.11(8), pp.1559-1565
1993
PMID: 8336195
Metrics
7 Record Views